Skip to Main Content

Paper Details

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma.
Blood
75
2021
Author NameAffiliation
Andrew M EvensRutgers Cancer Institute of New Jersey
  • 1 - 1

Datasets

Release 1.2